Healius Limited (HLS.AX) Stock Analysis & Winston Score

Healius is an Australian healthcare company that runs pathology labs and imaging centers. Its pathology business collects blood, tissue, and other samples from patients and tests them to help doctors diagnose illnesses. It also operates diagnostic imaging clinics where patients get X-rays, MRIs, and ultrasounds. The main customers are everyday patients, referred by their doctors, across Australia. Healius makes most of its money by billing Medicare, Australia's public health insurance system, for each test or scan performed. It operates almost entirely within Australia and is one of the country's two largest pathology providers, alongside Sonic Healthcare. However, the company is currently losing money, with negative operating and returns on capital, and it has been selling assets to reduce debt. The key risk is whether management can cut costs and return the core pathology business to profitability before its financial position deteriorates further.